Drug intelligence / Profile preview

qingfei paidu decoction

Development stage
Phase 3
Lead developer
State Administration of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Qingfei Paidu Decoction is a compounded traditional Chinese medicine (TCM) formula developed for the prevention and treatment of COVID-19 and other acute respiratory infections. It was promoted by the National Health Commission of China as a general prescription during the COVID-19 pandemic. The formula is based on modifications of several classical TCM prescriptions, including Maxing Shigan Decoction, Wuling Powder, Xiaochaihu Decoction, and Shegan Mahuang Decoction[1][2][6]. Qingfei Paidu Decoction consists of 21 herbal ingredients such as Ephedra (9g), Radix glycyrrhizae (6g), Almonds (9g), raw gypsum (15g), Ramulus Cinnamomi (9g), Rhizoma alismatis (9g), Polyporus umbellatus (9g), Atractylodes japonica Koidzumi (9g), Poria (15g), Bupleurum (16g), Scutellaria baicalensis root (6g), Ginger-processed Pinellia ternata tuber (9g), Ginger rhizome (9g), Radix et Rhizoma Asteris tatarici root/rhizome(9 g); Flos Farfarae flower bud(9 g); Rhizoma Belamcandae rhizome(9 g); Radix et Rhizoma Asari root/rhizome(6 g); Rhizoma Dioscoreae yam rhizome(12 g); Fructus Aurantii Immaturus immature bitter orange fruit(6 g); Pericarpium Citri Reticulatae tangerine peel(6 g); Herba Agastachis pogostemon herb(9 g)[2][5][6]. Mechanistically, QFPDD exerts anti-infective, anti-inflammatory, immunomodulatory and multi-organ protective effects through multiple targets and pathways. It has been shown to inhibit viral replication—including SARS-CoV-2—reduce lung inflammation and epithelial cell damage in models of acute lung injury[1][2]. Network pharmacology studies have identified hundreds of putative protein targets for its active compounds[3], suggesting broad modulation across immune response pathways.

Brand names
Clear Lung Detoxification Soup
Other names
QFPDDQFPD清肺排毒汤
02

Targets

Cyp (Cyclophilin family)C5AR1 (Complement C5a receptor 1)

Beyond the preview

Go deeper on qingfei paidu decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on qingfei paidu decoction.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call